Actively Recruiting
Randomized Study Comparing Early Neonatal and Infant Surgery for Tetralogy of Fallot
Led by Beijing Anzhen Hospital · Updated on 2025-09-10
160
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
Child health is essential for overall public health, and neonatal mortality is a key indicator of a nations health standards. In China, congenital heart disease CHD is the most common birth defect, with about 70,000-80,000 newborns affected yearly, including nearly 10,000 with critical congenital heart disease CCHD. Tetralogy of Fallot TOF, a major form of CCHD, causes serious heart defects that lead to low oxygen levels and life-threatening symptoms, requiring surgical repair to improve survival and quality of life. Despite advances, long-term outcomes after TOF surgery still present challenges, especially related to preserving pulmonary valve function and reducing heart rhythm problems.
CONDITIONS
Brief Title
Investigation of Tetralogy of Fallot in Neonates
Research Team
Q
Qiang Wang Prof Beijing Anzhen Hospital,Capital Medical University
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
